About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:5428435
Allelic
Composition
Apoetm1Unc/Apoetm1Unc
Cyp19a1tm1Esi/Cyp19a1tm1Esi
Genetic
Background
involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Apoetm1Unc mutation (22 available); any Apoe mutation (64 available)
Cyp19a1tm1Esi mutation (1 available); any Cyp19a1 mutation (6 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
growth/size/body
• increased body weight at 3, 6, and 12 months of age (J:184647)
• increased body weight at 3, 6, and 12 months of age (J:184647)

cardiovascular system
• 3 month old mutants exhibit small aortic root lesions that are extensive at 6 months of age (J:184647)
• double mutants tend to have slightly larger lesion sizes than single Apoe mutants (J:184647)
• 3 month old mutants exhibit small aortic root lesions that are extensive at 6 months of age (J:184647)
• double mutants tend to have slightly larger lesion sizes than single Apoe mutants (J:184647)
• mutants develop large atherosclerotic lesions in the aortic root by 12 months of age; lesions are advanced in development and show a clear fibrous component (J:184647)
• however there is little evidence of atherosclerotic plaque formation within the thoracic aorta with only small lesion development seen in the thoracic aorta at 12 months of age (J:184647)
• mutants develop large atherosclerotic lesions in the aortic root by 12 months of age; lesions are advanced in development and show a clear fibrous component (J:184647)
• however there is little evidence of atherosclerotic plaque formation within the thoracic aorta with only small lesion development seen in the thoracic aorta at 12 months of age (J:184647)
• mutants have moderately increased mean arterial blood pressure at 3 months of age (J:184647)
• mutants have moderately increased mean arterial blood pressure at 3 months of age (J:184647)
• mutants develop hypertension by 6 months of age which is sustained in older animals (J:184647)
• mutants develop hypertension by 6 months of age which is sustained in older animals (J:184647)

adipose tissue
• mutants exhibit an increase in adipocyte size with a larger mean diameter compared to wild-type adipocytes, however no difference in the number of individual adipocytes (J:184647)
• mutants exhibit an increase in adipocyte size with a larger mean diameter compared to wild-type adipocytes, however no difference in the number of individual adipocytes (J:184647)
• increase in gonadal adipose (J:184647)
• increase in gonadal adipose (J:184647)

homeostasis/metabolism
• 3 month old mutants show a small elevation in baseline blood glucose concentration after an overnight fast (J:184647)
• 3 month old mutants show a small elevation in baseline blood glucose concentration after an overnight fast (J:184647)
• mutants of all ages show reduced plasma insulin levels (J:184647)
• mutants of all ages show reduced plasma insulin levels (J:184647)
• random-fed non-fasting mutants show an increase in serum cholesterol levels (J:184647)
• random-fed non-fasting mutants show an increase in serum cholesterol levels (J:184647)
• plasma levels of C-reactive protrein (CRP), IL-6, and TNF-alpha are increased in 12 month old mutants (J:184647)
• plasma levels of C-reactive protrein (CRP), IL-6, and TNF-alpha are increased in 12 month old mutants (J:184647)
• mutants administered a bolus of glucose show elevated plasma glucose (J:184647)
• mutants administered a bolus of glucose show elevated plasma glucose (J:184647)
• 3 month old mutants show a blunted plasma glucose response in response to exogenous insulin administration; this blunted response becomes more pronounced with age (J:184647)
• 3 month old mutants show a blunted plasma glucose response in response to exogenous insulin administration; this blunted response becomes more pronounced with age (J:184647)

immune system
• plasma levels of C-reactive protrein (CRP), IL-6, and TNF-alpha are increased in 12 month old mutants (J:184647)
• plasma levels of C-reactive protrein (CRP), IL-6, and TNF-alpha are increased in 12 month old mutants (J:184647)

liver/biliary system
• from 6 months of age, livers begin to show yellow coloration (J:184647)
• from 6 months of age, livers begin to show yellow coloration (J:184647)
• increase in liver weight at 3 and 6 months of age (J:184647)
• increase in liver weight at 3 and 6 months of age (J:184647)
• 3 month old mutants start to show small lipid droplets forming within livers which become more pronounced at 6 and 12 months of age (J:184647)
• 3 month old mutants start to show small lipid droplets forming within livers which become more pronounced at 6 and 12 months of age (J:184647)


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Tumor Biology (MTB), Gene Ontology (GO), MouseCyc
Citing These Resources
Funding Information
Warranty Disclaimer & Copyright Notice
Send questions and comments to User Support.
last database update
02/02/2016
MGI 6.02
The Jackson Laboratory